Defective germinal center selection results in persistence of self-reactive B cells from the primary to the secondary repertoire in Primary Antiphospholipid Syndrome

原发性抗磷脂综合征中,生发中心选择缺陷导致自身反应性B细胞从初级B细胞库持续存在于次级B细胞库中。

阅读:3
作者:Yannick Dieudonné # ,Raquel Lorenzetti # ,Julien Rottura,Iga Janowska,Quentin Frenger,Léa Jacquel ,Olivier Vollmer ,Francesco Carbone,Zhu Chengsong,Marine Luka,Sabine Depauw,Nadège Wadier,Stéphane Giorgiutti ,Benoît Nespola,Agathe Herb,Reinhard Edmund Voll,Aurélien Guffroy ,Vincent Poindron,Mickaël Ménager,Thierry Martin ,Pauline Soulas-Sprauel ,Marta Rizzi ,Anne-Sophie Korganow ,Vincent Gies      0

Abstract

Primary antiphospholipid syndrome (PAPS) is a life-threatening clotting disorder mediated by pathogenic autoantibodies. Here we dissect the origin of self-reactive B cells in human PAPS using peripheral blood and bone marrow of patients with triple-positive PAPS via combined single-cell RNA sequencing, B cell receptors (BCR) repertoire profiling, CITEseq analysis and single cell immortalization. We find that antiphospholipid (aPL)-specific B cells are present in the naive compartment, polyreactive, and derived from the natural repertoire. Furthermore, B cells with aPL specificities are not eliminated in patients with PAPS, persist until the memory and long-lived plasma cell stages, likely after defective germinal center selection, while becoming less polyreactive. Lastly, compared with the non-PAPS cells, PAPS B cells exhibit distinct IFN and APRIL signature as well as dysregulated mTORC1 and MYC pathways. Our findings may thus elucidate the survival mechanisms of these autoreactive B cells and suggest potential therapeutic targets for the treatment of PAPS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。